Literature DB >> 11401939

Autosomal recessive catecholamine- or exercise-induced polymorphic ventricular tachycardia: clinical features and assignment of the disease gene to chromosome 1p13-21.

H Lahat1, M Eldar, E Levy-Nissenbaum, T Bahan, E Friedman, A Khoury, A Lorber, D L Kastner, B Goldman, E Pras.   

Abstract

BACKGROUND: Catecholaminergic polymorphic ventricular tachycardia (PVT) is characterized by episodes of syncope, seizures, or sudden death in response to physiological or emotional stress. In 2 families with autosomal dominant inheritance, the disease gene was mapped to chromosome 1q42-43. The objectives of this study were to characterize the clinical features of the disease in a Bedouin tribe from Israel and to map the disease gene. METHODS AND
RESULTS: In this Bedouin tribe, 9 children (age, 7+/-4 years) from 7 related families have died suddenly during the past decade, and 12 other children suffered from recurrent syncope and seizures starting at the age of 6+/-3 years. Parents of affected individuals were asymptomatic and were all related (first-, second-, or third-degree cousins). Segregation analysis suggested autosomal recessive inheritance. All 12 symptomatic patients and 1 asymptomatic sibling (mean age, 13+/-7 years) were found to have a relative resting bradycardia (64+/-13 bpm, versus 93+/-12 bpm in the unaffected siblings), as well as PVT induced by treadmill or isoproterenol infusion and appearing at a mean sinus rate of 110+/-10 bpm. Patients responded favorably to treatment with beta-blockers. A genome-wide search using polymorphic DNA markers mapped the disease locus to a 16-megabase interval on chromosome 1p13-21. A maximal lod score of 8.24 was obtained with D1S189 at theta=0.00. Sequencing of KCND3, a gene that encodes an I(tO) potassium channel transporter, did not reveal any significant sequence alterations.
CONCLUSIONS: This unique form of autosomal recessive PVT affects young children and may be lethal if left untreated. Linkage analysis maps this disorder to chromosome 1p13-21.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11401939     DOI: 10.1161/01.cir.103.23.2822

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  55 in total

1.  In situ confocal imaging in intact heart reveals stress-induced Ca(2+) release variability in a murine catecholaminergic polymorphic ventricular tachycardia model of type 2 ryanodine receptor(R4496C+/-) mutation.

Authors:  Biyi Chen; Ang Guo; Zhan Gao; Sheng Wei; Yu-Ping Xie; S R Wayne Chen; Mark E Anderson; Long-Sheng Song
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-06-21

Review 2.  The molecular autopsy: should the evaluation continue after the funeral?

Authors:  David J Tester; Michael J Ackerman
Journal:  Pediatr Cardiol       Date:  2012-02-04       Impact factor: 1.655

Review 3.  Cardiac and skeletal muscle disorders caused by mutations in the intracellular Ca2+ release channels.

Authors:  Silvia G Priori; Carlo Napolitano
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

4.  Protein kinase A-dependent biophysical phenotype for V227F-KCNJ2 mutation in catecholaminergic polymorphic ventricular tachycardia.

Authors:  Amanda L Vega; David J Tester; Michael J Ackerman; Jonathan C Makielski
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-08-25

Review 5.  Genetics of sudden cardiac death.

Authors:  Alon Barsheshet; Andrew Brenyo; Arthur J Moss; Ilan Goldenberg
Journal:  Curr Cardiol Rep       Date:  2011-10       Impact factor: 2.931

Review 6.  Calsequestrin mutations and catecholaminergic polymorphic ventricular tachycardia.

Authors:  Michela Faggioni; Dmytro O Kryshtal; Björn C Knollmann
Journal:  Pediatr Cardiol       Date:  2012-03-16       Impact factor: 1.655

7.  Optimizing catecholaminergic polymorphic ventricular tachycardia therapy in calsequestrin-mutant mice.

Authors:  Guy Katz; Assad Khoury; Efrat Kurtzwald; Edith Hochhauser; Eyal Porat; Asher Shainberg; Jonathan G Seidman; Christine E Seidman; Abraham Lorber; Michael Eldar; Michael Arad
Journal:  Heart Rhythm       Date:  2010-07-08       Impact factor: 6.343

8.  Bidirectional ventricular tachycardia due to coronary allograft vasculopathy a unique presentation.

Authors:  Sanjeev P Bhavnani; Christopher A Clyne
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-08-13       Impact factor: 1.468

9.  Plakophilin-2 Truncation Variants in Patients Clinically Diagnosed With Catecholaminergic Polymorphic Ventricular Tachycardia and Decedents With Exercise-Associated Autopsy Negative Sudden Unexplained Death in the Young.

Authors:  David J Tester; Jaeger P Ackerman; John R Giudicessi; Nicholas C Ackerman; Marina Cerrone; Mario Delmar; Michael J Ackerman
Journal:  JACC Clin Electrophysiol       Date:  2018-11-01

Review 10.  Nhlh2: a basic helix-loop-helix transcription factor controlling physical activity.

Authors:  Deborah J Good; Christopher A Coyle; Dana L Fox
Journal:  Exerc Sport Sci Rev       Date:  2008-10       Impact factor: 6.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.